Scalp

Sequential Bio wins prestigious Allē Award: Recognised as "Most Significant" Testing Method in the Industry

Retrieved on: 
Monday, October 3, 2022

Sequential Bio is the B2B microbiome testing arm for Sequential Skin Ltd, which has developed the world's first end-to-end platform for companies to evaluate their products on the microbiome in vivo.

Key Points: 
  • Sequential Bio is the B2B microbiome testing arm for Sequential Skin Ltd, which has developed the world's first end-to-end platform for companies to evaluate their products on the microbiome in vivo.
  • "The All Award gives us strong confidence in the testing platform and capabilities we've built in Sequential Bio.
  • Please get in touch [email protected] if you are launchingmicrobiome products and want to have first-in-class testing done by our experts at Sequential Bio.
  • Sequential Bio has validated its AI-driven testing platform with over 30 companies, analyzing over 12,000 skin microbiome samples.

Aileron Therapeutics Announces Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from Chemotherapy-Induced Damage at the European Society for Dermatological Research Annual Meeting 2022

Retrieved on: 
Friday, September 30, 2022

It is yet another burden layered on top of their already-daunting fight against cancer, said Dr. Paus.

Key Points: 
  • It is yet another burden layered on top of their already-daunting fight against cancer, said Dr. Paus.
  • Ailerons vision is to bring chemoprotection to all patients with p53-mutated cancer regardless of the type of cancer or chemotherapy.
  • We look forward to our anticipated data readouts from that trial later this year and into 2023.
  • Aileron previously conducted in vitro studies showing that ALRN-6924 protected human fibroblasts in cell culture from multiple chemotherapies, but not p53-mutant breast cancer cells.

Anuncia Medical, Inc., clearance for the ReFlow® System Mini for the treatment of patients with hydrocephalus

Retrieved on: 
Friday, September 30, 2022

Anuncia Medical announced FDA clearance of ReFlow System Mini for the treatment of cerebrospinal fluid (CSF) disorders.

Key Points: 
  • Anuncia Medical announced FDA clearance of ReFlow System Mini for the treatment of cerebrospinal fluid (CSF) disorders.
  • The FDA 510(k) clearance allows Anuncia Medical to commercialize the ReFlow System Mini in the US.
  • "This is very exciting news for Anuncia and for the hydrocephalus community," said Elsa Chi Abruzzo, President & CEO of Anuncia.
  • The ReFlow System Mini has a ReFlow Mini Flusher and ReFlow Ventricular Catheter.

IOWA CANCER SPECIALISTS HELPS CANCER PATIENTS KEEP THEIR HAIR

Retrieved on: 
Thursday, September 29, 2022

DAVENPORT, Iowa, Sept. 29, 2022 /PRNewswire/ -- Iowa Cancer Specialists announced today that The DigniCap® Scalp Cooling System is now available at 1750 E 53rd Street in Davenport to minimize hair loss from chemotherapy. Positive results from the multi-center FDA clinical trial, published in February 2017 by The Journal of the American Medical Association (JAMA), indicate that seven out of ten patients using the DigniCap system kept at least 50% of their hair.

Key Points: 
  • DAVENPORT, Iowa, Sept. 29, 2022 /PRNewswire/ -- Iowa Cancer Specialists announced today that The DigniCap Scalp Cooling System is now available at 1750 E 53rd Street in Davenport to minimize hair loss from chemotherapy.
  • "For many patients hair loss is a very troublesome side effect of chemotherapy," said Dr. Susannah Friemel of Iowa Cancer Specialists.
  • "DigniCap provides patients with a means to reduce hair loss while maintaining their privacy and self-esteem.
  • We believe this is a significant advantage in caring for the whole patient and are proud to make this technology available to patients at Iowa Cancer Specialists."

Procter & Gamble Hair Care Brands Gold Series by Pantene and Royal Oils by Head & Shoulders Announce Awardees of $1 Million #RootedinScience Scholarship

Retrieved on: 
Wednesday, September 28, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220928005353/en/
    Gold Series and Royal Oils and has committed to providing $1 Million in total scholarships to support the growth and development of future Black STEM-focused innovators.
  • A 2019 Pew Research Center study revealed that Black professionals remain underrepresented in the STEM workforce, making up nearly 9%.
  • Gold Series from Pantene was formulated by Black scientists, Ph.Ds., dermatologists and stylists who understand the unique needs of textured hair and provide superior moisturization.
  • Through decades of cutting-edge innovation and technology, plus on-going research of textured hair, Royal Oils by Head & Shoulders was also developed to deliver superior scalp care and moisturization for any style.

InventHelp Inventor Develops Dispensing Tool for Hair/Scalp Products (LJD-151)

Retrieved on: 
Tuesday, September 27, 2022

My mess-free design can be used with conditioners, hot oil treatments, hair coloring and other products."

Key Points: 
  • My mess-free design can be used with conditioners, hot oil treatments, hair coloring and other products."
  • The patent-pending invention provides an effective way to dispense hair treatments onto the hair and scalp.
  • In doing so, it offers an alternative to traditional methods of applying hair and scalp products.
  • The original design was submitted to the New Jersey sales office of InventHelp.

InventHelp Inventors Develop Beautiful and Innovative Line of Bandanas (HAD-182)

Retrieved on: 
Monday, September 26, 2022

PITTSBURGH, Sept. 26, 2022 /PRNewswire/ -- "We wanted to create an innovative line of bandanas to help cancer patients and others dealing with hair loss feel confident and beautiful again," said one of two inventors, from North Miami Beach, Fla., "so we invented the VICTORIA.

Key Points: 
  • PITTSBURGH, Sept. 26, 2022 /PRNewswire/ -- "We wanted to create an innovative line of bandanas to help cancer patients and others dealing with hair loss feel confident and beautiful again," said one of two inventors, from North Miami Beach, Fla., "so we invented the VICTORIA.
  • The invention provides a beautiful and innovative bandana designed to provide a more comfortable and natural looking hairstyle for individuals experiencing hair loss or thinning hair.
  • In doing so, it offers an alternative to wearing traditional wigs, bandanas or head scarves.
  • 21-HAD-182, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

InventHelp Inventors Develop Beautiful and Innovative Line of Bandanas (HAD-182)

Retrieved on: 
Monday, September 26, 2022

PITTSBURGH, Sept. 26, 2022 /PRNewswire/ -- "We wanted to create an innovative line of bandanas to help cancer patients and others dealing with hair loss feel confident and beautiful again," said one of two inventors, from North Miami Beach, Fla., "so we invented the VICTORIA.

Key Points: 
  • PITTSBURGH, Sept. 26, 2022 /PRNewswire/ -- "We wanted to create an innovative line of bandanas to help cancer patients and others dealing with hair loss feel confident and beautiful again," said one of two inventors, from North Miami Beach, Fla., "so we invented the VICTORIA.
  • The invention provides a beautiful and innovative bandana designed to provide a more comfortable and natural looking hairstyle for individuals experiencing hair loss or thinning hair.
  • In doing so, it offers an alternative to wearing traditional wigs, bandanas or head scarves.
  • 21-HAD-182, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

Arcutis Announces Positive Topline Results from ARRECTOR Pivotal Phase 3 Trial of Roflumilast Foam 0.3% in Scalp and Body Psoriasis

Retrieved on: 
Monday, September 26, 2022

Roflumilast foam is a selective and potent PDE4 inhibitor that has been uniquely formulated as an emollient, water-based, moisturizing foam that can be used on the scalp and body.

Key Points: 
  • Roflumilast foam is a selective and potent PDE4 inhibitor that has been uniquely formulated as an emollient, water-based, moisturizing foam that can be used on the scalp and body.
  • These data demonstrate that investigational roflumilast foam, if approved, could provide both an effective and well-tolerated new treatment option for scalp and body psoriasis.
  • Roflumilast foam was well-tolerated, and the overall safety and tolerability profile was consistent with previously published studies of roflumilast cream 0.3% and foam.
  • Roflumilast foam is a once-daily topical foam formulation of roflumilast which the Company is developing for both seborrheic dermatitis and scalp and body psoriasis.

EQS-News: PRECISIS GmbH: EASEE – ­­­World's first minimally invasive brain pacemaker for the treatment of epilepsy receives CE-certification and is available immediately

Retrieved on: 
Friday, September 23, 2022

Heidelberg, 23.09.2022 after seven years of development work, Precisis GmbH, headquartered in Heidelberg, has received the CE certification for its minimally invasive brain pacemaker EASEE.

Key Points: 
  • Heidelberg, 23.09.2022 after seven years of development work, Precisis GmbH, headquartered in Heidelberg, has received the CE certification for its minimally invasive brain pacemaker EASEE.
  • These drug-refractory patients wait an average of 22 years before they are offered further technical or surgical treatment options.
  • With this new, risk-minimized EASEE method, the treatment spectrum is expanded in the early phases of the disease."
  • EASEE is an acronym for Epicranial Application of Stimulation Electrodes for Epilepsy.